-
α-Bungarotoxin in Translational Cholinergic Research
2026-08-30
α-Bungarotoxin is more than a receptor antagonist: it is a causal probe for testing how α7 nicotinic acetylcholine receptor signaling shapes inflammation, cell death, and tissue function. This article connects nicotinic receptor blockade with recent placental necroptosis findings and offers a practical framework for translational study design.
-
Octyl-α-ketoglutarate for HIF-1α Studies
2026-08-29
Octyl-α-ketoglutarate is a cell-permeable prolyl hydroxylase substrate for testing whether α-ketoglutarate availability changes HIF-1α turnover in metabolically rewired cells. This practical guide converts IDH and TCA-cycle hypotheses into controlled dosing, hypoxia comparisons, and orthogonal readouts, with troubleshooting for solvent, timing, and interpretation.
-
Nelfinavir Mesylate: Virology to Ferroptosis
2026-08-28
Nelfinavir Mesylate is a high-value HIV-1 protease inhibitor for antiviral assays and a mechanistic probe for DDI2–NFE2L1 control of ferroptosis. This workflow-focused guide shows how to separate HIV replication suppression from proteostasis and cell-death effects while improving solubility, controls, and assay interpretation.
-
Ibrexafungerp Against Resistant Candida auris
2026-08-28
Wiederhold and colleagues show that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when therapy began after infection was established. The study is important because it connects resistance-aware susceptibility testing with an oral glucan-synthesis inhibitor and delayed-treatment efficacy, while providing a useful benchmark for interpreting cell-wall-active antifungal agents.
-
(R)-MG132: A Rigorous Control for Cancer Metabolism
2026-08-27
(R)-MG132 is a functionally inactive MG-132 enantiomer designed to strengthen proteasome inhibition validation. This article shows how it can clarify whether metabolic and post-transcriptional phenotypes, including the HNRNPU–PHGDH axis, are genuinely proteasome-dependent or arise from confounding effects.
-
Hexetidine (NSC-17764): Translational Strategy
2026-08-27
Hexetidine (NSC-17764) offers translational researchers a practical model for studying broad-spectrum oral antimicrobial activity without reducing performance to a single MIC value. This article connects membrane-level biology, adsorption and washout effects, biofilm assay design, and clinical-use considerations to support more predictive oral infection workflows.
-
T7 RNA Polymerase for Precise RNA Synthesis
2026-08-26
T7 RNA Polymerase is a recombinant enzyme expressed in E. coli that selectively transcribes RNA from DNA templates carrying a T7 promoter. Its defined template requirements support in vitro transcription, RNA vaccine production, antisense RNA and RNAi research, and RNA structure-function studies.
-
(-)-Arctigenin MEK1 Inhibitor Workflows
2026-08-26
(-)-Arctigenin provides a chemically controlled way to interrogate LPS–NF-κB–iNOS signaling alongside MEK1 biology. This guide translates macrophage extracellular-vesicle findings in breast cancer into practical treatment, co-culture, invasion, and pathway-validation workflows.
-
Atorvastatin as a Ferroptosis Research Probe
2026-08-25
Atorvastatin is more than an HMG-CoA reductase inhibitor: it is a practical probe for connecting mevalonate biology, ferroptosis, and disease-specific phenotypes. This guide translates recent hepatocellular carcinoma findings into rigorous assay and interpretation decisions.
-
Myriocin Workflows for Sphingolipid Research
2026-08-25
Myriocin provides a direct pharmacological route to suppress serine palmitoyltransferase and interrogate de novo sphingolipid synthesis. This workflow-focused guide connects lipid measurements with SPTLC2 biology, cardiac remodeling models, cancer research, and cell cycle regulation while emphasizing controls, dosing logic, and troubleshooting.
-
BET Inhibition in HPV-16-Associated HNSCC
2026-08-24
The reference preprint examines how BET protein inhibition affects viral and cellular transcription in HPV-16-associated head and neck squamous cell carcinoma. Its central finding is that responses are heterogeneous across models: BET inhibition consistently suppresses key viral and growth-related programs in some contexts, but E6 loss does not uniformly restore p53 signaling or produce the same downstream phenotype.
-
DDI2–NFE2L1 Proteostasis Protects Against Ferroptosis
2026-08-24
The reference study shows that ferroptosis triggers a compensatory ubiquitin–proteasome response governed by DDI2-dependent activation of NFE2L1. Disrupting this pathway reduces proteasome function, increases protein ubiquitylation, and sensitizes cells to ferroptotic death, identifying the DDI2–NFE2L1 axis as a mechanistic link between proteostasis and oxidative cell injury.
-
DDI2–NFE2L1 Control of Ferroptosis
2026-08-23
The reference study identifies DDI2-mediated cleavage of NFE2L1 as a critical adaptive mechanism that restores proteasome function during ferroptotic stress. Its genetic, chemical, and proteomic experiments show how disrupting this pathway increases protein ubiquitylation, weakens proteasomal activity, and sensitizes cells to ferroptosis, including with nelfinavir.
-
Linoleic Acid (C18:2) Assay Workflow Guide
2026-08-22
Linoleic Acid (SKU C3108) provides a defined omega-6 fatty acid input for oxidative stress, membrane, erythrocyte, migration, and nutritional deficiency studies. It is water-insoluble, requires solvent-based preparation, and is best used with freshly prepared solutions rather than long-term stored stocks.
-
DiscoveryProbe Protease Inhibitor Library: Assay Design
2026-08-22
The DiscoveryProbe Protease Inhibitor Library supports mechanism-aware protease inhibition studies across biochemical and cellular models. This guide explains how to convert a broad inhibitor collection into defensible HTS, HCS, apoptosis, cancer, and infectious disease workflows.